Accordingly, in the diabetic environment a strategy of IGF-1/IGF-1R overexpression ameliorated the pathophysiological progress of DCM through antioxidative and anti-inflammatory processes [12–14]. This evidence concerns the gene IGF1R and familial dilated cardiomyopathy.